Microglial TREM2 was identified as a critical modulator for neuroinflammation and cognitive function in AD, whereas its involvement in SCI remains largely unknown (Gao et al., 2023; Zhao T. et al., 2025). Here, TREM2 is linked to Alzheimer disease.